Top Markets
Coin of the day
Destiny Pharma plc Destiny Pharma plc

Destiny Pharma plc

DEST
Clasificación en acciones #41146
Destiny Pharma plc is a biotechnology company based in Brighton, UK, founded in... Destiny Pharma plc is a biotechnology company based in Brighton, UK, founded in 1996, specializing in the identification, progression, and market introduction of pharmaceutical solutions for infectious diseases. The company's clinical pipeline includes NTCD-M3, currently in Phase III trials to prevent recurring Clostridioides difficile infections. Its XF-73 program features XF-73 Nasal, undergoing Phase II development for the prevention of post-surgical staphylococcal infections, and XF-73 Dermal, which is in Phase I for treating bacterial skin infections resistant to antibiotics. Additionally, Destiny Pharma's preclinical efforts involve SPOR-COV, a biotherapeutic product aimed at preventing COVID-19 and other viral respiratory diseases, and XF Drugs Biofilm, targeting antibiotic-resistant biofilm and bacterial aggregate infections. The company is also investigating further applications of its XF drugs for respiratory, oral mucosa, and ocular infections. Destiny Pharma maintains strategic alliances with various organizations, including China Medical System Holdings Limited, SporeGen Limited, the University of Southampton, Aston University, the University of Sheffield, Cardiff University, and Tianjin Medical University.
Precio por acción
$0.04082105
Última sincronización: 2024-08-12
Capitalización bursátil
$39.09K
Cambio (1 día)
-19.83%
Cambio (1 año)
0.00%
País
GB
Comercio Destiny Pharma plc (DEST)

Categoría

Ganancias de Destiny Pharma plc (DEST)
Ganancias en Dec 2023 TTM: $-8.21M
Secondo gli ultimi rapporti finanziari di Destiny Pharma plc, gli utili attuali della società sono $-8.21M. Nel 2022, la società ha registrato un utile di $-9.33M, una disminución en comparación con agli utili del 2021, che erano di $-8.48M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Destiny Pharma plc desde 2013 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
2026 (TTM) $-8.21M 0.00%
2023 $-8.21M -12.04%
2022 $-9.33M 10.03%
2021 $-8.48M -4.31%
2020 $-8.86M 21.02%
2019 $-7.32M -4.32%
2018 $-7.65M 76.32%
2017 $-4.34M 142.61%
2016 $-1.79M 1.42%
2015 $-1.76M -45.18%
2014 $-3.22M 174.64%
2013 $-1.17M 0.00%
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
$5.27B -64,380.54%
US
$1.95B -23,870.85%
NL
- -
CH
- -
KR
$3.01B -36,728.02%
BE